Telotwin Tablet 80/5 mg

Adult dose

The recommended dosage of this drug is one tablet once daily, taken with water regardless of meals. It is recommended to take it daily at the same time (e.g., in the morning). For patients with renal impairment, mild and moderate renal impairment do not require dosage adjustment, but those with severe renal impairment should start treatment at a lower dose and increase gradually. For patients with liver impairment, the daily dose should not exceed 40 mg.

Child dose

Safety and efficacy for pediatric patients under 18 years of age have not been established, and therefore use of this drug is not recommended.

This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should not be used by women who are pregnant or may become pregnant. This drug should not be used in patients with certain conditions, such as severely impaired liver function, heart valve disease, severe hypotension, cardiac shock, or unstable heart failure after acute myocardial infarction. Patients with primary aldosteronism, specific heart conditions, liver disorders, gastrointestinal diseases, renal artery hypertension, dialysis patients, and the elderly should use this drug with caution. Dizziness and peripheral edema are common side effects of this drug. Rarely, fainting or severe adverse reactions may occur, so immediate consultation with healthcare professionals is advised if symptoms are severe. This drug should not be taken during pregnancy, and if pregnancy is confirmed, use should be stopped immediately, and alternative treatment should be sought. It is also safe for breastfeeding women not to take this drug. Safety and efficacy for pediatric patients under 18 years of age have not been sufficiently established, and therefore use is not recommended. When administering to the elderly, dosage should be carefully adjusted, and it is recommended to start with a lower dose, especially in those over 75 years old. In case of overdose, symptoms such as hypotension, dizziness, and abnormal heart rate may occur; hence immediate medical attention should be sought. This drug may interact with other medications; therefore, it is essential to inform healthcare professionals if taking other drugs, particularly potassium supplements or diuretics. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. This drug contains sorbitol and is not advisable for patients with fructose intolerance. Store in a secure place out of reach of children, and it is best to take it immediately after opening.

Serious side effects

Severe allergic reactions (hives, angioedema, anaphylaxis), severe skin adverse reactions (severe rash, toxic skin rash, Stevens-Johnson syndrome, exfoliative dermatitis), respiratory issues (dyspnea, interstitial lung disease), liver problems (jaundice, hepatitis, yellowing of the skin or eyes associated with increased liver enzymes), severe neurological symptoms (severe headache, fainting, altered consciousness), serious edema or urinary abnormalities (generalized edema, acute kidney failure,

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This drug is sensitive to light; hence it should be stored in a container that protects it from light. Additionally, the drug should be stored at a temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]